Table 6 Examples of primary outcomes reported in ClinicalTrials.gov register with primary outcome reported in abstract classified as “partial agreement”
Abstract | ClinicalTrials.gov | Classified as | |
|---|---|---|---|
1 | Retinal thickness in the peak oedematous field on the retinal maps of the fast module scans of the Stratus OCT | Retinal thickness by fast retinal thickness mapping by optical coherence tomography at 0,2,4,8,10,15,20,30,60,90,120,and 180 min after last swallow of glycerol | Extra information in ClinicalTrials.gov |
2 | Visual acuity | Mean change in best corrected visual acuity as assessed by number letters read correctly on ETDRS eye chart at starting test distance of 4 meters from baseline to 1,3,6 months | Extra information in ClinicalTrials.gov |
3 | ETDRS best corrected visual acuity at 2, 6 and 12 weeks; OCT at 2 and 6 weeks; fluorescein angiography at 2 and 6 weeks | Best corrected visual acuity, OCT foveal thickness, fluorescein angiogram | Extra information in abstract |
4 | Change from baseline in major symptom complex score over period 1, consisting of runny nose, sniffles, itchy nose, nose blows, sneezes, and watery eyes | Mean change from baseline of major symptoms related to seasonal allergic rhinitis | Extra information in abstract |
5 | Retinal detachment rate; surgery-related complications; patient comfort; refractive change; visual acuity; OCT | Retinal detachment rate at 6 months | Extra complementary information in both sources |